Rheumatoid Arthritis Clinical Trials in San Antonio

Showing 681-700 of 1,334 trials

Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy

NCT04692688

The objective of this study is to evaluate the safety and efficacy of APX3330 to treat diabetic retinopathy (DR) and diabetic macular edema (DME).

Diabetic RetinopathyDiabetic Macular EdemaNPDR - Non Proliferative Diabetic Retinopathy+1 more

Ocuphire Pharma, Inc.103 participantsStarted Apr 2021

Phoenix, Arizona, United States • Bakersfield, California, United States • Beverly Hills, California, United States +21 more locations

COMPLETEDPHASE3< 1 mile

An Open-label Safety and Pharmacokinetic Study of INL-001 in Adults Following Various Open Soft-Tissue Surgeries

NCT04785638

This is a multicenter, Phase 3, open-label, safety, tolerability, and characterization of pharmacokinetics study of the INL 001 (bupivacaine HCl) implant, at 300 mg, in patients following various soft-tissue surgeries: open ventral hernia repair, abdominoplasty, open abdominal hysterectomy, laparoscopic-assisted colectomy, and reduction mammoplasty.

Pain, PostoperativeHernia, VentralAbdominoplasty+3 more

Innocoll100 participantsStarted Apr 2021

Florence, Alabama, United States • Sheffield, Alabama, United States • Pasadena, California, United States +5 more locations

Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy

An Open-label Safety and Pharmacokinetic Study of INL-001 in Adults Following Various Open Soft-Tissue Surgeries

Rheumatoid Arthritis Trials in Other Cities

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

Efficacy, Tolerability, and Safety of DFN-15

The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System

Post-Market Registry of AURYON™ Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease

Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine

Safety and Efficacy in Adult Subjects With Acute Migraines

Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder

Expanded Access Protocol Using 131I-MIBG

Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)

Formula Tolerance of Term Infants

Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity

Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16

Spinal Cord Stimulation in the Treatment of Chronic, Intractable Pain Using the Nalu™ Neurostimulation System

Study to Evaluate the PK of BMS-927711 in Patient With Migraine During Acute Migraine and Non-migraine Condition

Thoracolumbar Burst Fractures Study Comparing Surgical Versus Non-surgical Treatment

Other Conditions in San Antonio